Next Article in Journal
The Statin Target HMG-Coenzyme a Reductase (Hmgcr) Regulates Sleep Homeostasis in Drosophila
Previous Article in Journal
The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin
pharmaceuticals-logo
Article Menu

Article Menu

Article

A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis

1
Clinical Pharmacology Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain
2
Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Faculty of Medicine, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), 28006 Madrid, Spain
3
Clinical Trial Unit, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain
4
Medical Information Unit, Instituto de Investigación Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, 28006 Madrid, Spain
5
Internal Medicine Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain
6
Internal Medicine Department, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, 28006 Madrid, Spain
7
Microbiology Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain
8
Preventive Medicine Department, Hospital Universitario de La Princesa, Faculty of Medicine, Instituto de Investigación Sanitaria La Princesa (IP), Universidad Autónoma de Madrid (UAM), 28006 Madrid, Spain
*
Authors to whom correspondence should be addressed.
A complete list of the members of the [email protected] Working Group and other collaborators from Hospital Universitario de la Princesa is provided in the Supplementary Materials.
Academic Editors: Alan J. Hibbitts and Sofia A. Papadimitriou
Pharmaceuticals 2022, 15(1), 78; https://doi.org/10.3390/ph15010078
Received: 21 December 2021 / Revised: 1 January 2022 / Accepted: 4 January 2022 / Published: 8 January 2022
Data from several cohorts of coronavirus disease 2019 (COVID-19) suggest that the most common comorbidities for severe COVID-19 disease are the elderly, high blood pressure, and diabetes; however, it is not currently known whether the previous use of certain drugs help or hinder recovery. This study aims to explore the association of previous hospitalisation use of medication on the mortality of COVID-19 disease. A retrospective case-control from two hospitals in Madrid, Spain, included all patients aged 18 years or above hospitalised with a diagnosis of COVID-19. A Propensity Score matching (PSM) analysis was performed. Confounding variables were considered to be age, sex, and the number of comorbidities. Finally, 3712 patients were included. Of these, 687 (18.5%) patients died (cases). The 22,446 medicine trademarks used previous to admission were classified according to the ATC, obtaining 689 final drugs; all of them were included in PSM analysis. Eleven drugs displayed a reduction in mortality: azithromycin, bemiparine, budesonide-formoterol fumarate, cefuroxime, colchicine, enoxaparin, ipratropium bromide, loratadine, mepyramine theophylline acetate, oral rehydration salts, and salbutamol sulphate. Eight final drugs displayed an increase in mortality: acetylsalicylic acid, digoxin, folic acid, mirtazapine, linagliptin, enalapril, atorvastatin, and allopurinol. Medication associated with survival (anticoagulants, antihistamines, azithromycin, bronchodilators, cefuroxime, colchicine, and inhaled corticosteroids) may be candidates for future clinical trials. Drugs associated with mortality show an interaction with the underlying conditions. View Full-Text
Keywords: coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); hospitalisation; mortality; previous medication; risk factor; propensity score matching analysis coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); hospitalisation; mortality; previous medication; risk factor; propensity score matching analysis
Show Figures

Graphical abstract

MDPI and ACS Style

Monserrat Villatoro, J.; Mejía-Abril, G.; Díaz García, L.; Zubiaur, P.; Jiménez González, M.; Fernandez Jimenez, G.; Cancio, I.; Arribas, J.R.; Suarez Fernández, C.; Mingorance, J.; García Rodríguez, J.; Villagrasa Ferrer, J.R.; Carcas, A.J.; Frías, J.; Abad-Santos, F.; Borobia, A.M.; Ramírez, E.; on behalf of the [email protected] Working Group and Other Collaborators from Hospital Universitario de la Princesa. A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals 2022, 15, 78. https://doi.org/10.3390/ph15010078

AMA Style

Monserrat Villatoro J, Mejía-Abril G, Díaz García L, Zubiaur P, Jiménez González M, Fernandez Jimenez G, Cancio I, Arribas JR, Suarez Fernández C, Mingorance J, García Rodríguez J, Villagrasa Ferrer JR, Carcas AJ, Frías J, Abad-Santos F, Borobia AM, Ramírez E, on behalf of the [email protected] Working Group and Other Collaborators from Hospital Universitario de la Princesa. A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals. 2022; 15(1):78. https://doi.org/10.3390/ph15010078

Chicago/Turabian Style

Monserrat Villatoro, Jaime, Gina Mejía-Abril, Lucía Díaz García, Pablo Zubiaur, María Jiménez González, Guillermo Fernandez Jimenez, Inés Cancio, José R. Arribas, Carmen Suarez Fernández, Jesús Mingorance, Julio García Rodríguez, José R. Villagrasa Ferrer, Antonio J. Carcas, Jesús Frías, Francisco Abad-Santos, Alberto M. Borobia, Elena Ramírez, and on behalf of the [email protected] Working Group and Other Collaborators from Hospital Universitario de la Princesa. 2022. "A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis" Pharmaceuticals 15, no. 1: 78. https://doi.org/10.3390/ph15010078

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop